Inactive Instrument

Insiders Puma Biotechnology Inc OTC Bulletin Board

Equities

PBYI

US74587V1070

Real-time Estimate Cboe BZX Other stock markets 03:57:17 2024-05-02 pm EDT			5-day change	1st Jan Change
4.93 ^USD	0.00%		0.00%	0.00%

Mar. 20	Puma Biotechnology Plans to Start Breast Cancer Combination Study in Second Half; Shares Rise	MT
Mar. 20	Puma Biotechnology, Inc. Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Puma Biotechnology, Inc. Appoints Alessandra Cesano to Its Board of Directors	22-08-02	CI
Puma Biotechnology, Inc Announces Resignation of Ann Miller as Its Director, Effective December 31, 2021	21-12-14	CI
Puma Biotechnology, Inc. Appoints Allison Dorval to the Board of Directors and Audit Committee of the Board	21-07-14	CI
Insider Trends: Puma Biotechnology Insider Continues 90-Day Selling Trend	21-06-15	MT
Insider Trends: 90-Day Insider Selling Trend Prolonged at Puma Biotechnology	21-06-11	MT
Insider Trends: Puma Biotechnology Insider Continues 90-Day Selling Trend	21-06-11	MT
Insider Trends: 90-Day Insider Selling Trend Prolonged at Puma Biotechnology	21-06-11	MT
Puma Biotechnology, Inc Announces Resignation of Richard Bryce as Chief Medical and Scientific Officer; Effective April 5, 2021	21-03-29	CI
Puma Biotechnology, Inc. Announces Alan H. Auerbach's Retirement from the Board	21-02-23	CI
Insider Trends: Insider Sales Continue 90-Day Trend at Puma Biotechnology	21-01-06	MT
Puma Biotechnology, Inc. Announces Board Changes	20-07-08	CI
Puma Biotechnology, Inc. Appoints Jeff J. Ludwig as Chief Commercial Officer	20-03-23	CI
Puma Biotechnology, Inc. Appoints Ann C. Miller to Board of Directors	19-11-13	CI
Puma Biotechnology, Inc. Appoints Hugh O'Dowd to the Board of Directors and Commercial Committee of the Board	19-10-17	CI
Puma Biotechnology Announces Resignation of Steven Lo as Chief Commercial Officer, Effective October 18, 2019	19-10-08	CI
Puma Biotechnology, Inc. Announces Retirement of Charles R. Eyler as Senior Vice President of Finance and Administrator and Treasurer	19-02-12	CI
Puma Biotechnology, Inc. Announces Management Changes	18-11-09	CI
Puma Biotechnology, Inc. Appoints Michael P. Miller to its Board	18-02-27	CI
Puma Biotechnology, Inc. Appoints Douglas Hunt as Senior Vice President of Regulatory Affairs	18-01-03	CI
Puma Biotechnology, Inc. Approves Promotion of Richard P. Bryce from Senior Vice President, Clinical Research and Development to Chief Medical and Scientific Officer	17-08-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Puma Biotechnology Inc OTC Bulletin Board

Equities

PBYI

US74587V1070

Insiders

Filters